Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01306539 · ClinicalTrials.gov registry record · NA

Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's Disease

A NA study of Parkinson's Disease, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT01306539 is a NA study of Parkinson's Disease that has completed, run by University of California, San Diego. The registered enrollment target is 20 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01306539, a NA study of Parkinson's Disease, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Stimulation of the subthalamic nucleus will have effects on various aspects of neuropsychiatric function.

Conditions Studied

Parkinson's Disease

Interventions

  • PROCEDURE Stimulation of the subthalamic nucleus

Study Locations (1)

California

  • Scripps Clinic Torrey Pines - La Jolla

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2008-07
Est. Completion 2014-12
Phase NA

Sponsor

University of California, San Diego

775 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01306539

The ClinicalTrials.gov registry entry for NCT01306539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (97% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Stimulation of the subthalamic nucleus is the first listed.

NCT01306539 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01306539 about?

NCT01306539 is a clinical study titled "Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's Disease". Stimulation of the subthalamic nucleus will have effects on various aspects of neuropsychiatric function.

What is the current status of trial NCT01306539?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2008-07. Estimated completion is 2014-12.

What conditions does trial NCT01306539 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT01306539?

The interventions under investigation include: Stimulation of the subthalamic nucleus (PROCEDURE).

Who is sponsoring clinical trial NCT01306539?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01306539 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.